Maria Palasis
2022
In 2022, Maria Palasis earned a total compensation of $1.7M as President and Chief Executive Officer at Lyra Therapeutics, a 1% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $273,000 |
|---|---|
| Option Awards | $870,601 |
| Salary | $583,000 |
| Other | $9,150 |
| Total | $1,735,751 |
Palasis received $870.6K in option awards, accounting for 50% of the total pay in 2022.
Palasis also received $273K in non-equity incentive plan, $583K in salary and $9.2K in other compensation.
Rankings
In 2022, Maria Palasis' compensation ranked 1,981st out of 5,739 executives tracked by ExecPay. In other words, Palasis earned more than 65.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,981 out of 5,739 | 66th |
Division Manufacturing | 1,056 out of 3,128 | 66th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 124 out of 485 | 74th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 82 out of 347 | 76th |
Industry Surgical and Medical Instruments and Apparatus | 70 out of 253 | 72nd |
Source: SEC filing on April 25, 2023.
Palasis' colleagues
We found two more compensation records of executives who worked with Maria Palasis at Lyra Therapeutics in 2022.